Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,185 | -10,500 | -6,559 | -2,738 | -9,648 |
| Depreciation Amortization | 382 | 285 | 187 | 92 | 336 |
| Accounts receivable | 556 | 550 | 556 | 556 | 88 |
| Other Working Capital | 170 | 89 | 1,788 | 706 | -1,057 |
| Other Operating Activity | 358 | -221 | -366 | -386 | 451 |
| Operating Cash Flow | $-12,719 | $-9,797 | $-4,394 | $-1,770 | $-9,830 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -52 | -44 | -40 | -25 | -240 |
| Investing Cash Flow | $-52 | $-44 | $-40 | $-25 | $-240 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 38,505 | 38,505 | 38,505 | 2,072 | 35,783 |
| Other Financing Activity | -39 | -30 | -19 | -9 | -121 |
| Financing Cash Flow | $38,466 | $38,475 | $38,486 | $2,063 | $35,662 |
| Beginning Cash Position | 33,060 | 33,060 | 33,060 | 33,060 | 7,468 |
| End Cash Position | 58,755 | 61,694 | 67,112 | 33,328 | 33,060 |
| Net Cash Flow | $25,695 | $28,634 | $34,052 | $268 | $25,592 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,719 | -9,797 | -4,394 | -1,770 | -9,830 |
| Capital Expenditure | -52 | -44 | -40 | -25 | -240 |
| Free Cash Flow | -12,771 | -9,841 | -4,434 | -1,795 | -10,070 |